Ridgeline Discovery GmbH

Ridgeline is Versant’s newest discovery engine and has laboratories at Tech Park Basel. Ridgeline’s leadership team hails from Roche and has a proven track record in drug development.

News

News

Monte Rosa Therapeutics – From Versant’s Ridgeline engine to a publicly traded biotech

From Versant’s Ridgeline engine and a single Tech Park Basel lab to a publicly traded biotech on the Nasdaq exchange.

News

$300M – SixPeaks acquired by AstraZeneca

from idea at Tech Park Basel to a strategic exit with a global pharma leader.

Building B2
Industry Accelerator
Employees 74
Founding year 2000